• By:admin

New Trial Coming for Johnson & Johnson

An appeals court recently ruled that Johnson & Johnson deserves a new trial after the company was ordered by a jury to pay $417 million to a woman who alleged her cancer was caused by her use of the company’s Baby Powder.

Despite there being enough evidence to uphold the ruling that the company did not warn the public of the potential health risks associated with the use of talc-based products, the appeals court found there was “conflicting evidence” regarding the link to cancer.

The ruling comes after several recent defeats for Johnson & Johnson, all claiming it knew its product was dangerous but failed to do anything about it.

In June, a California jury ordered the company to pay $10 million to a woman dying of cancer who alleged her disease was caused by use of the powder products. In May, a jury awarded a woman $325 million to a woman with cancer.

A Johnson & Johnson spokesperson responded to the appeals court ruling stating, that the company was looking forward to retrying the case and again demonstrating in court “that talc does not cause ovarian cancer.” He also noted other recent verdicts in favor of plaintiffs had been thrown out.

The company has also filed several motions to bar expert testimony in 12,000 upcoming cases. A decision regarding how those cases will proceed is not expected until the end of 2019. If Johnson & Johnson wins the motions those case would likely be dismissed.

The lawsuits filed against Johnson & Johnson claim that use of its powder products led consumers to develop ovarian and mesothelioma. The latter is a rare type of cancer linked to exposure to asbestos, a known carcinogenic substance often found in talc. Johnson & Johnson denies its products ever contained asbestos and stands by its argument that talc is not linked to cancer.

The company has been preparing for thousands of upcoming talc trials throughout the United States. All of the cases claim that Johnson & Johnson, and its subsidiary company Janssen, are responsible for plaintiffs developing cancer after using powdered products including Johnson & Johnson Baby Powder and Johnson & Johnson Shower-to-Shower powder.

If the trend of cases moving forward in favor of plaintiffs continues, it is expected that additional lawsuits will be filed by women who have been affected by their use of the products.

Johnson & Johnson said it would appeal several recent verdicts, claiming they have no bearing on the “medical, scientific, or regulatory conclusions about a product,” and that its products have been tested and “no traces of asbestos contamination using the most sensitive techniques available” were found.

Dangers of Talc

Talc continues to be found in cosmetics, powders, and other personal care products.

Johnson & Johnson is facing tens of thousands of lawsuits claiming its talc-based powder products are contaminated with asbestos and that their use caused women to develop mesothelioma and reproductive cancers.

In some of the cases against Johnson & Johnson, plaintiffs’ attorneys argue that the company knew its products were contaminated with asbestos. They also claim they can prove their allegations through internal company documents that reveal awareness of the dangers of the products.

There has been no definitive link between the use of talcum powder and cancer established by the medical community, but studies do show some women who use these products in the genital area tend to experience an increased risk for developing cancer.

Johnson & Johnson has agreed to comply with all government investigations and to provide any information it has related to the Department of Justice’s, the SEC’s, and the Senate Committee on Health, Education, Labor, and Pensions’ ongoing investigations.

Related Post

VIEW all
weight loss drug
Weight Loss Drug Removed from Market after Cancer Linked Identified
  • By:bshaffer

Eisai, Inc. voluntarily pulled its weight-loss drug Belviq from the market in February 2020 after it was determined that the drug poses a slightly increased risk of cancer. Despite the recall of the product, Eisai said it did not believe the FDA’s interpretation of the latest round of data on the drug’s safety and stated that it still believes the benefits outweigh the risks. According to the FDA, patients currently using Belviq should stop doing so immediately. They should dispose …

man with heartburn
More Lawsuits Filed against Maker of Popular Heartburn Medication after April FDA Recall
  • By:admin

Additional lawsuits have been filed against the manufacturers of Zantac, a popular medication used to treat heartburn and acid reflux. The new round of legal action comes after the US Food and Drug Administration (FDA) announced on April 1, 2020, that it is requesting manufacturers of the drug to remove it from the market immediately. According to the FDA, the drug puts users at risk for exposure to N-Nitrosodimethylamine (NDMA), a known carcinogen. The use of the medication could result …

covid19 drugs
Additional Concerns about Valsartan Arise Amid COVID-19 Pandemic
  • By:admin

Valsartan is a hypertension medication and used to treat heart failure. It lowers the risk of heart attack. Valsartan blocks angiotensin II from constricting blood vessels. It also reduces high blood pressure by activating aldosterone. It works by binding with angiotensin type I receptors. It’s an antagonist but works differently than other ACE inhibitors drugs that block the conversion of angiotensin I to angiotensin II. In 2019, users of Valsartan began filing lawsuits against the drug’s manufacturer claiming the use …

Have you been affected by a drug or device listed?